KR0138527B1 - 벤조 디아제핀 화합물 및 이의 제조방법 - Google Patents

벤조 디아제핀 화합물 및 이의 제조방법

Info

Publication number
KR0138527B1
KR0138527B1 KR1019890011365A KR890011365A KR0138527B1 KR 0138527 B1 KR0138527 B1 KR 0138527B1 KR 1019890011365 A KR1019890011365 A KR 1019890011365A KR 890011365 A KR890011365 A KR 890011365A KR 0138527 B1 KR0138527 B1 KR 0138527B1
Authority
KR
South Korea
Prior art keywords
alkyl
hydrogen
compound
formula
cycloalkyl
Prior art date
Application number
KR1019890011365A
Other languages
English (en)
Other versions
KR900003179A (ko
Inventor
쿠마르 차크 라바르 티 지반
마이클 호텐 테렌스
Original Assignee
티. 알. 크라우터
릴리 인더스트리즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 티. 알. 크라우터, 릴리 인더스트리즈 리미티드 filed Critical 티. 알. 크라우터
Publication of KR900003179A publication Critical patent/KR900003179A/ko
Application granted granted Critical
Publication of KR0138527B1 publication Critical patent/KR0138527B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용없슴

Description

벤조디아제핀 화합물 및 이의 제조 방법
본 발명은 신규한 화합물, 이의 제조방법 및 약제로서의 이의 용도에 관한 것이다.
약제학적 특성을 가진 여러가지 트리사이클릭 화합물은 이미 연구되어 왔으며, 예를 들면, 영국 특허 제 1,533,235호에는 이러한 형태의 몇가지 티에노-벤조 디아제핀 화합물이 기술되어 있다. 당해 화합물은 중추신경계에 대해 유용한 활성을 갖는다고 기재되어 있다.
본 발명의 화합물은 하기 일반식(I)의 티아졸로 [1,5]벤조디아제핀 및 이의 산 부가염이다.
1 2 3 4 1-4 2-4 1-4 1-4 1-4 1-4 5 7 1-6 3-7 1-4 2-6 8 1-4 7 6 1-10 3-7 3-7 1-4 1-4 1-4 1-4 1 2 3 2 1-4 6 1-6 3-7 3-7 1-4 1-4 7 1-4 8
1-10 1-6 1-4 1-4 1-4 1-4 1-4 1-4 1-4 2-4 3-7 3-7 1-4 7 2-6 1-20 10-12 7 2 6 7 1-4 1 4 8 2 3 6 1-4 7 1-4 7 7 1-6 3-7 1-4 2-6 5 7 7 1-6 3-7 1-4 2-6 7 1-6 3-7 1-4 2-6 1 6 5 2 2 5 5 5 4 5 4 7 7 5 7 7 7 4 5 1 4 6 9 1-4 5 2
50

Claims (7)

  1. 하기 일반식(I)의 화합물 및 이의 산 부가염.
    Figure kpo00013
    상기식에서,
    R1,R2,R3및 R4는 각각 독립적으로 수소, C1-4알킬, C2-4알케닐, 할로겐, C1-4할로알킬, 니트로, C1-4알콕시, C1-4할로알콕시, C1-4알킬티오 또는 페닐설포닐이고;
    R5는 일반식
    Figure kpo00014
    의 그룹 [여기서,
    R7은 수소, C1-6알킬, C3-7사이클로알킬, C1-4알킬, 벤질 또는 ZO-C2-6알킬(여기서, Z는 수소 또는 아실 그룹이다)이고, R8은 수소 또는 C1-4알킬이고, n은 0 또는 1인데, 단 R7이 수소이면 n은 0이다]이며;
    R6은 수소, C1-10알킬, C3-7사이클로알킬, C3-7사이클로 알킬 C1-4알킬, C1-4할로알킬, C1-4알콕시 또는 C1-4알킬티오이고;
    Figure kpo00015
    Figure kpo00016
    Figure kpo00017
    중에서 선택된 티아졸 환이다.
  2. 제 1항에 있어서, 티아졸 환이
    Figure kpo00018
    인 화합물.
  3. 제 1항에 있어서, 티아졸 환이
    Figure kpo00019
    인 화합물.
  4. 제 2항에 있어서, 하기 일반식의 화합물.
    Figure kpo00020
    상기식에서,
    R1,R2,R3및 R4는 각각 독립적으로 수소, 할로겐 또는 C1-4할로알킬이고, R6은 수소, C1-6알킬, C3-7사이클로알킬, C3-7사이클로알킬 C1-4알킬 또는 C1-4알킬티오이며,
    R7은 수소 또는 C1-4알킬이다.
  5. 제 4항에 있어서, R1및 R4가 수소이고, R2및 R3가 각각 독립적으로 수소 또는 할로겐이며, R6이 C1-4알킬이고, R7이 C1-4알킬인 화합물.
  6. 일반식 R5H의 아민을 일반식(III)의 화합물과 반응시켜 일반식(I)의 화합물 또는 이의 산 부가염을 제조하는 방법.
    Figure kpo00021
    상기식에서,
    R1내지 R6및 X는 제1항에서 정의한 바와 같고,
    Q는 아민 R5H의 수소원자와 함께 분리될 수 있는 라디칼이다.
  7. 하기 일반식(IV)의 중간체 화합물.
    Figure kpo00022
    상기식에서,
    R1,R2,R3,R4,R6및 X는 제 1항에서 정의한 바와 같고,
    R9는 에스테르 그룹이다.
KR1019890011365A 1988-08-11 1989-08-10 벤조 디아제핀 화합물 및 이의 제조방법 KR0138527B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819059A GB8819059D0 (en) 1988-08-11 1988-08-11 Benzodiazepine compounds & their use as pharmaceuticals
GB8819059.0 1988-08-11

Publications (2)

Publication Number Publication Date
KR900003179A KR900003179A (ko) 1990-03-23
KR0138527B1 true KR0138527B1 (ko) 1998-05-15

Family

ID=10641942

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890011365A KR0138527B1 (ko) 1988-08-11 1989-08-10 벤조 디아제핀 화합물 및 이의 제조방법

Country Status (22)

Country Link
US (2) US4977150A (ko)
EP (1) EP0354781B1 (ko)
JP (1) JP2779219B2 (ko)
KR (1) KR0138527B1 (ko)
CN (1) CN1025857C (ko)
AR (1) AR246972A1 (ko)
AT (1) ATE113600T1 (ko)
AU (1) AU625067B2 (ko)
CA (1) CA1318669C (ko)
DE (1) DE68919154T2 (ko)
DK (1) DK393489A (ko)
ES (1) ES2062012T3 (ko)
GB (1) GB8819059D0 (ko)
HU (1) HU202239B (ko)
IE (1) IE64598B1 (ko)
IL (1) IL91246A (ko)
MX (1) MX17107A (ko)
NZ (1) NZ230251A (ko)
PH (1) PH27010A (ko)
PT (1) PT91401B (ko)
RU (1) RU2002752C1 (ko)
ZA (1) ZA896039B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1004596A4 (fr) * 1990-09-26 1992-12-22 Therabel Res S A N V Derives de methylpiperazinoazepine, leur preparation et leur utilisation.
US5627178A (en) 1991-04-23 1997-05-06 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5393752A (en) * 1992-05-26 1995-02-28 Therabel Research S.A./N.V. Methylpiperazinoazepine compounds, preparation and use thereof
US6034078A (en) * 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
CA2479932A1 (en) 2002-03-28 2003-10-09 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
AU2003264915A1 (en) 2002-08-05 2004-02-25 Eli Lilly And Company Piperazine substituted aryl benzodiazepines
EP1664063A1 (en) * 2003-09-09 2006-06-07 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
ATE511512T1 (de) * 2005-01-05 2011-06-15 Lilly Co Eli Olanzapinpamoat-dihydrat

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH468400A (de) * 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
GB1292410A (en) * 1970-05-13 1972-10-11 Yoshitomi Pharmaceutical Thienobenzothiazepine derivatives
CH554362A (de) * 1970-07-30 1974-09-30 Spofa Vereinigte Pharma Werke Verfahren zur herstellung von neuen estern tricyklischer piperazinoalkanole.
US3897446A (en) * 1973-09-04 1975-07-29 Upjohn Co 6-Phenylthiazolo{8 3,2-a{9 {8 1,4{9 benzodiazepin-1-(2H)-ones, and processes
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US3951981A (en) * 1975-02-24 1976-04-20 American Cyanamid Company Substituted benzodiazepines and method of use
US4404137A (en) * 1979-10-16 1983-09-13 Lilly Industries Limited Pyrazolo [3,4-b][1,5]benzodiazepine compounds
US4431589A (en) * 1980-12-11 1984-02-14 Lilly House Benzodiazepine compounds and their use as pharmaceuticals

Also Published As

Publication number Publication date
EP0354781A2 (en) 1990-02-14
AU3939989A (en) 1990-02-15
EP0354781B1 (en) 1994-11-02
DK393489A (da) 1990-02-12
IL91246A0 (en) 1990-03-19
ATE113600T1 (de) 1994-11-15
IL91246A (en) 1994-01-25
ES2062012T3 (es) 1994-12-16
IE64598B1 (en) 1995-08-23
CA1318669C (en) 1993-06-01
MX17107A (es) 1993-08-01
GB8819059D0 (en) 1988-09-14
HU202239B (en) 1991-02-28
AR246972A1 (es) 1994-10-31
CN1025857C (zh) 1994-09-07
PT91401A (pt) 1990-03-08
RU2002752C1 (ru) 1993-11-15
CN1040798A (zh) 1990-03-28
AU625067B2 (en) 1992-07-02
HUT53109A (en) 1990-09-28
PH27010A (en) 1993-02-01
JPH02104591A (ja) 1990-04-17
DE68919154D1 (de) 1994-12-08
PT91401B (pt) 1995-05-04
ZA896039B (en) 1991-04-24
DK393489D0 (da) 1989-08-10
US5051516A (en) 1991-09-24
US4977150A (en) 1990-12-11
JP2779219B2 (ja) 1998-07-23
EP0354781A3 (en) 1991-04-03
KR900003179A (ko) 1990-03-23
IE892576L (en) 1990-02-11
NZ230251A (en) 1992-05-26
DE68919154T2 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
DE69021755D1 (de) Benzopyranderivate und Verfahren zu ihrer Herstellung.
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CA2152486A1 (en) Anticonvulsant sorbopyranose sulfamates
ATE36149T1 (de) Antikonvulsive sulfamatderivate.
BG60262B2 (en) Process for the preparation of substituted bicyclic compounds
KR0138527B1 (ko) 벤조 디아제핀 화합물 및 이의 제조방법
ATE63124T1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
DE69215965D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
ATE63913T1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
FR2801587B1 (fr) Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2358406A1 (fr) Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques, leur obtention et leur application a titre de medicament
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
KR910004633A (ko) 신규한 2-옥소-1옥사-8-아자스피로[4,5]데칸 유도체와 이들을 포함하는 약학적 조성물 및 그 제조방법
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
HU903266D0 (en) Process for producing amine-derivatives and pharmaceutical preparatives containing these compounds as active substance
WO1989001330A3 (en) W-arylsulphonamidoalkanoic acids for treatment of thromboxane mediated diseases
IL73372A (en) (5-phenyl-1,3-dioxan-4-yl)alkenoic or alkanoic acid derivatives,their preparation and pharmaceutical compositions containing them
ATE168371T1 (de) 5-amino-5,6,7,8-tetrahydrochinoline und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
KR890008142A (ko) 6,7-디히드로-[1,2,4]트리아졸로[1,5-a][1,3,5]트리아진-2-술폰아미드, 그의 제조방법 및 제초제 및 식물 생장 조절제로서의 용도
DE3531453A1 (de) Substituierte 7-oxomitosan-verbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende, pharmazeutische mittel
DE3750117D1 (de) Verfahren zur Herstellung von Indolinon-2-Derivaten.
US3857854A (en) 6-phenyl-1h,4h-{8 1,2,4{9 oxadiazalo{8 4,3-2{9 {8 1,4{9 benzodiazepin-1-ones
PT86625A (pt) Process for the preparation of dipyrazoles useful as bronchodilators
KR890009919A (ko) 4- 헤테로아릴-1,3- 벤조디아제핀 및 2-치환된-α-(헤테로아릴) 벤젠에탄아민, 이의 제조방법 및 약제로서의 이의 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20010111

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee